Hagerah S. Malik

Hagerah S. Malik

Auto-generated profile, based on publicly available information

Hagerah S. Malik

University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2020 in Journal of Virology
Verified
Journal Article
Closed access
ASAlexandra Y. Soare
Alexandra Y. Soare
HMHagerah S. Malik
Hagerah S. Malik
NDNatasha D. Durham
Natasha D. Durham
TFTracey Freeman
Tracey Freeman
RARaymond Alvarez
Raymond Alvarez
TSTalia Swartz
Talia Swartz
While effective treatment can lower the severe morbidity and mortality associated with HIV-1 infection, patients infected with HIV-1 suffer from significantly higher rates of noncommunicable comorbidities associated with chronic inflammation. Emerging literature suggests a key role for P2X1 receptors in mediating this chronic inflammation, but the mechanism is still unknown. Here, we demonstrate that HIV-1 infection is reduced by P2X1 receptor antagonism. This inhibition is mediated by interference with HIV-1 Env and can impact a variety of viral clades. These observations highlight the importance of P2X1 antagonists as potential novel therapeutics that could serve to block a variety of different viral clades with additional benefits for their anti-inflammatory properties.